Sakar Healthcare Financials

SAKAR Stock   294.10  5.85  2.03%   
We advise to exercise Sakar Healthcare fundamental analysis to see if markets are presently undervaluing or overvaluing the firm. In other words, this technique allows you to confirm available indicators of Sakar Healthcare as well as the relationship between them. We were able to collect data for twenty-five available drivers for Sakar Healthcare Limited, which can be compared to its competition. The stock experiences an unexpected upward trend. Watch out for market signals. Check odds of Sakar Healthcare to be traded at 352.92 in 90 days. Key indicators impacting Sakar Healthcare's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Operating Income520.3 M495.5 M
Sufficiently Up
Slightly volatile
  
Understanding current and past Sakar Healthcare Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Sakar Healthcare's financial statements are interrelated, with each one affecting the others. For example, an increase in Sakar Healthcare's assets may result in an increase in income on the income statement.

Sakar Healthcare Stock Summary

Sakar Healthcare competes with Kingfa Science, Rico Auto, GACM Technologies, COSMO FIRST, and Tribhovandas Bhimji. Sakar Healthcare is entity of India. It is traded as Stock on NSE exchange.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentIndia Stock View All
ExchangeNational Stock Exchange of India
ISININE732S01012
Business Address406, Silver Oaks
SectorPharmaceuticals
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.sakarhealthcare.com
Phone91 79 2658 4655
You should never invest in Sakar Healthcare without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Sakar Stock, because this is throwing your money away. Analyzing the key information contained in Sakar Healthcare's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Sakar Healthcare Key Financial Ratios

Sakar Healthcare's financial ratios allow both analysts and investors to convert raw data from Sakar Healthcare's financial statements into concise, actionable information that can be used to evaluate the performance of Sakar Healthcare over time and compare it to other companies across industries.

Sakar Healthcare Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets1.2B1.8B2.7B3.4B4.0B4.1B
Other Current Liab4.9M22.4M52.9M37.4M59.7M62.7M
Net Debt164.0M425.1M928.3M1.1B790.9M453.3M
Retained Earnings310.0M409.4M558.9M688.6M805.4M845.6M
Accounts Payable54.4M197.8M305.0M260.9M274.5M288.3M
Cash3.0M824.6K298K933K2.6M2.2M
Other Assets146.8M260.5M(1K)70.3M65.4M56.1M
Net Receivables82.3M123.7M141.8M220.8M209.2M121.3M
Inventory109.3M157.0M141.8M154.0M280.6M294.7M
Other Current Assets21.1M55.7M145.2M149.2M225.0M236.3M
Total Liab338.0M793.4M1.4B1.6B1.3B719.3M
Total Current Assets216.5M337.2M500.2M559.2M716.1M751.9M
Short Term Debt41.4M41.5M78.5M187.4M244.0M256.2M
Other Liab70.9M76.2M85.3M102.7M118.1M79.5M
Net Tangible Assets780.4M977.2M1.3B1.7B2.0B2.1B
Long Term Debt124.7M384.5M850.1M982.3M1.1B1.2B
Long Term Debt Total124.7M384.5M850.1M982.3M1.1B1.2B
Short Long Term Debt42.3M41.5M45.2M130.2M149.7M157.2M
Cash And Equivalents3.0M824.7K1K933K839.7K797.7K
Net Invested Capital980.2M1.4B2.2B2.8B3.3B3.4B
Net Working Capital74.1M4.5M32.6M14.2M12.8M12.2M
Intangible Assets53.8M32.8M7.3M0.014.6M15.1M

Sakar Healthcare Key Income Statement Accounts

201920202021202220232024 (projected)
Total Revenue829.8M947.4M1.3B1.3B1.5B812.9M
Gross Profit391.8M432.5M534.1M598.1M699.6M377.4M
Operating Income136.0M151.3M206.4M191.2M495.5M520.3M
Ebit136.0M157.2M219.1M191.2M213.7M132.4M
Ebitda206.8M237.7M315.7M341.0M393.3M204.1M
Cost Of Revenue438.0M514.9M748.1M735.5M842.1M435.5M
Income Before Tax122.3M132.3M189.3M168.8M159.0M98.0M
Net Income96.2M106.8M152.4M127.6M116.7M74.6M
Income Tax Expense26.0M25.5M37.5M41.2M42.3M23.4M
Tax Provision26.0M25.5M37.5M41.2M47.4M27.4M
Interest Income12.2M24.8M14.1M59.5M68.4M71.8M
Interest Expense21.1M23.3M3.3M59.5M75.9M79.7M
Net Interest Income(22.4M)(24.8M)(29.0M)(59.5M)(53.5M)(50.9M)
Research Development478.0K120.9K1.1M7.5M5.5M2.9M

Sakar Healthcare Key Cash Accounts

201920202021202220232024 (projected)
Change To Inventory(40.8M)(47.6M)15.1M(12.1M)(123.3M)(117.2M)
Change In Cash(708.5K)(2.2M)(526K)634K3.7M3.9M
Free Cash Flow(35.4M)(209.7M)(618.3M)(468.8M)(350.9M)(333.4M)
Depreciation70.8M80.6M96.7M149.9M180.5M189.5M
Other Non Cash Items(6.7M)1.2M30.1M28.5M(1.0B)(996.7M)
Capital Expenditures136.7M355.5M975.3M822.0M595.6M301.0M
Net Income122.3M132.3M189.3M168.8M116.7M91.1M
End Period Cash Flow3.0M824.6K299K933K4.7M4.9M
Net Borrowings52.1M260.5M478.4M132.2M152.0M110.8M
Change To Netincome19.4M26.7M67.2M49.4M56.9M38.1M
Investments(136.8M)(468.3M)(70.9M)(743.8M)(669.4M)(635.9M)

Sakar Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Sakar Healthcare's current stock value. Our valuation model uses many indicators to compare Sakar Healthcare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sakar Healthcare competition to find correlations between indicators driving Sakar Healthcare's intrinsic value. More Info.
Sakar Healthcare Limited is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about  0.80  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Sakar Healthcare Limited is roughly  1.26 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Sakar Healthcare by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Sakar Healthcare's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Sakar Healthcare Systematic Risk

Sakar Healthcare's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Sakar Healthcare volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Execute Function
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Sakar Healthcare correlated with the market. If Beta is less than 0 Sakar Healthcare generally moves in the opposite direction as compared to the market. If Sakar Healthcare Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Sakar Healthcare is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Sakar Healthcare is generally in the same direction as the market. If Beta > 1 Sakar Healthcare moves generally in the same direction as, but more than the movement of the benchmark.

Sakar Healthcare Limited Total Assets Over Time

Sakar Healthcare Thematic Clasifications

Sakar Healthcare Limited is part of Health Management investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Healthcare providers, hospitals. Major hospitals and healthcare providers
Health ManagementView
This theme covers Healthcare providers, hospitals. Major hospitals and healthcare providers. Get More Thematic Ideas

Sakar Healthcare November 27, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Sakar Healthcare help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sakar Healthcare Limited. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sakar Healthcare Limited based on widely used predictive technical indicators. In general, we focus on analyzing Sakar Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sakar Healthcare's daily price indicators and compare them against related drivers.

Other Information on Investing in Sakar Stock

Sakar Healthcare financial ratios help investors to determine whether Sakar Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sakar with respect to the benefits of owning Sakar Healthcare security.